On December 28, 2017, the Australian share market was seen to perform well with some stocks gaining more traction than others.

Shares of Greencross Limited (ASX: GXL) surged up 4.8% with no specific news or update by the company. The investors seem to be looking to snap up the shares given the potential of the group to be unveiled in coming months at the back of 15 stores and 20 in-store clinics expected to be added to the network in FY18. We are positive on GXL’s mushrooming prospects.

Another player that zoomed up was Breville Group Ltd (ASX: BRG), up 3.7% despite any news, and the group is trading at high levels while working on its turnaround planned for distribution segment.

Shares of NEXTDC Ltd (ASX: NXT) edged slightly up at the back of the updates relating to latest announcement by Asia Pacific Data Centre Group on offering NEXTDC the sale of its portfolio at $300 million. NXT is in receipt of summary versions of first right of refusal notices in relation to the portfolio of APDC data centres, that include Sydney (S1) at $130M (plus GST), Melbourne (M1) at $110M (plus GST); and Perth (S1) at $60M (plus GST). The Company intends to formally reject each of the Offers under the first right of refusal notice on the grounds of unjustifiable value promoted by the 360 Capital-appointed Board of APDC. NXT’s action to wrap-up the APDC Trust is scheduled for 31 January 2018. Investors might want to stick around with this technology stock, going into 2018.

With the news that Marijuana is getting into a legitimate business with California becoming the largest region in the US to fully legalise recreational use by adults, pot stocks in Australia have been high. AusCann Group Holdings Ltd (ASX: AC8) moved up 13.2% while The Hydroponics Company Ltd (ASX: THC) rallied up 15%. Creso Pharma Ltd (ASX: CPH) was up 8% with the sector driven positive sentiment.  

On the other hand, real-estate group, Stockland’s shares (ASX: SGP) plunged 1.8% as the group traded ex-dividend. SGP had lately acquired prime land in Sydney’s North West for $398 million. Another player, which is our speculative pick for 2018 is Eclipx Group Ltd (ASX: ECX) that traded ex-dividend and slipped 2.8%. Our infrastructure-sector pick, Transurban Group (ASX: TCL) joined the above two and traded ex-dividend with a stock price fall of about 1.1%.

Retail Food Group Ltd (ASX: RFG)also plummeted by 5.6% post some gains after announcement of extension of debt facilities.

Disclaimer
 
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.